Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

http://update.bmn.com/browse/area/record?uid=UPDATE.Slifka02062003152

 

Research Update

 

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
Terajima , M. et al.
J. Exp. Med. 2003 197:927-932
MEDLINE   Full Text   
Commentary by Mark Slifka slifkam@ohsu.edu 
2 June 2003
Concern about the use of smallpox as a bioweapon has renewed interest in smallpox vaccination. However, testing new vaccine candidates has been complicated by the lack of knowledge regarding the T cell epitopes expressed both by smallpox (variola)and by vaccinia, the virus used for smallpox vaccination.

Terajima et al. used a human leukocyte antigen- (HLA-) binding prediction algorithm to identify potential immunogenic peptides and in vitro cytotoxic T lymphocyte (CTL) assays to confirm that two of the candidates were HLA-A*0201-restricted vaccinia epitopes. These two epitopes are well-conserved among other orthopoxviruses including Variolamajor, Variolaminor, Monkeypox and Cowpox. Following immunization with vaccinia, the immune response against these two peptides accounted for 6% to 35% of the total interferon gamma-producing peripheral blood mononuclear cells (PBMC) quantitated by ELISPOT assays.

Identification of these epitopes will enable the direct analysis and quantitation of the virus-specific CD8+ T cell responses during and after smallpox vaccination and represents a substantial step forward in the evaluation of future vaccine candidates.


© Elsevier Limited 2003

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.